| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 57,581 | New Holding | 57,581 | 100 % | $5,758 | $5,758 | $0 | 0.00 % | $0 | | | | | | News Article | History of Citadel L P Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Icahn Capital Lp | Institution | 3,459,459 | No Change | 0 | 0 % | $345,946 | $345,946 | $0 | 0.00 % | $0 | | | | | | News Article | History of Icahn Capital Lp Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Icahn Carl C Et Al | Institution | 864,865 | No Change | 0 | 0 % | $86,487 | $86,487 | $0 | 0.00 % | $0 | | | | | | News Article | History of Icahn Carl C Et Al Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 66,843 | Added More | 1,593 | 2.44 % | $6,684 | $6,684 | $0 | 0.00 % | $0 | | | | | | News Article | History of Northern Trust Corp Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Xaraf Management Llc | Institution | 33,200 | No Change | 0 | 0 % | $3,320 | $3,320 | $0 | 0.00 % | $0 | | | | | | News Article | History of Xaraf Management Llc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 100 | No Change | 0 | 0 % | $11 | $10 | $-1 | -9.09 % | $0 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geduld E E | Institution | 50,000 | No Change | 0 | 0 % | $5,500 | $5,000 | $-500 | -9.09 % | $0 | | | | | | News Article | History of Geduld E E Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -105,004 | -100 % | | | | -9.09 % | $1,050 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 620,000 | Added More | 240,400 | 63.32 % | $68,200 | $62,000 | $-6,200 | -9.09 % | $-2,404 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 260,344 | No Change | 0 | 0 % | $28,638 | $26,034 | $-2,603 | -9.09 % | $0 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 149,923 | No Change | 0 | 0 % | $14,992 | $14,992 | $0 | 0.00 % | $0 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 800 | New Holding | 800 | 100 % | $80 | $80 | $0 | 0.00 % | $0 | | | | | | News Article | History of Credit Suisse Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -9,665 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Highbridge Capital Management Llc | Institution | 1,292,264 | Added More | 64 | 0.00 % | $129,226 | $129,226 | $0 | 0.00 % | $0 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 201,419 | Added More | 160,564 | 393.00 % | $20,142 | $20,142 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ubs Ag Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 39,800 | No Change | 0 | 0 % | $4,378 | $3,980 | $-398 | -9.09 % | $0 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 36,802 | No Change | 0 | 0 % | $4,416 | $3,680 | $-736 | -16.66 % | $0 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 100 | No Change | 0 | 0 % | $13 | $10 | $-3 | -23.07 % | $0 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 72,698 | No Change | 0 | 0 % | $9,451 | $7,270 | $-2,181 | -23.07 % | $0 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Friedberg Investment Management | Institution | 2,000 | No Change | 0 | 0 % | $260 | $200 | $-60 | -23.07 % | $0 | | | | | | News Article | History of Friedberg Investment Management Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 19,542 | No Change | 0 | 0 % | $2,931 | $1,954 | $-977 | -33.33 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 17,260 | New Holding | 17,260 | 100 % | $2,589 | $1,726 | $-863 | -33.33 % | $-863 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-09-15 | 2009-03-31 | 13F-HR/A | Highbridge Capital Management Llc | Institution | 1,292,200 | Sold Some | -706,000 | -35.33 % | $206,752 | $129,220 | $-77,532 | -37.50 % | $42,360 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 149,923 | No Change | 0 | 0 % | $25,487 | $14,992 | $-10,495 | -41.17 % | $0 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 87,044 | New Holding | 87,044 | 100 % | $13,927 | $8,704 | $-5,223 | -37.50 % | $-5,223 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Adventrx Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 35,400 | No Change | 0 | 0 % | $5,664 | $3,540 | $-2,124 | -37.50 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Adventrx Pharmaceuticals Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |